Core Insights - Comstock Inc.'s strategic investee, Bioleum Corporation, has acquired substantially all patents and intellectual property assets of RenFuel K2B AB, including a patented catalytic esterification process [1][2] Financial Summary - The total purchase price for the acquisition is $18.1 million, which includes: - $12.5 million paid with 520,833 shares of Bioleum common stock - $2.5 million in warrants for an additional 104,167 shares at an exercise price of $24 per share - $2.6 million in debt forgiveness - $500,000 in cash - Additionally, there is a contingent earn-out payment of 3% of revenues from sales of lignin ester produced using the acquired technologies, capped at $11.9 million [2] Strategic Implications - Bioleum aims to convert woody biomass into renewable alternatives to petroleum, enhancing its technology stack with RenFuel's patented processes [3] - RenFuel's CEO expressed confidence that the transaction will maximize and accelerate the commercialization of their technologies globally [3] Licensing and Development Agreements - Bioleum has granted RenFuel an exclusive license to use the acquired technologies in biomaterials applications, subject to a 3% royalty [3] - A development services agreement has been established for ongoing technology development involving RenFuel's laboratory and pilot systems in Sweden [3] Termination of Previous Commitments - The transaction terminates a prior commitment by Bioleum to fund approximately $1 million per year to RenFuel under a previous agreement [4]